Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
TTNP Titan Pharmaceuticals, Inc. daily Stock Chart
TTNP [NASD]
Titan Pharmaceuticals, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-0.38 Insider Own0.30% Shs Outstand95.66M Perf Week-8.04%
Market Cap17.80M Forward P/E- EPS next Y-0.15 Insider Trans0.00% Shs Float95.38M Perf Month-17.59%
Income-17.00M PEG- EPS next Q-0.04 Inst Own6.10% Short Float7.36% Perf Quarter-53.82%
Sales4.80M P/S3.71 EPS this Y7.90% Inst Trans-11.48% Short Ratio1.06 Perf Half Y-27.33%
Book/sh0.02 P/B9.44 EPS next Y-15.40% ROA-179.30% Target Price- Perf Year-43.64%
Cash/sh0.06 P/C3.24 EPS next 5Y- ROE- 52W Range0.14 - 0.59 Perf YTD-2.73%
Dividend- P/FCF- EPS past 5Y3.20% ROI-307.70% 52W High-67.93% Beta0.83
Dividend %- Quick Ratio1.60 Sales past 5Y-0.20% Gross Margin76.40% 52W Low32.96% ATR0.02
Employees21 Current Ratio1.80 Sales Q/Q160.00% Oper. Margin- RSI (14)33.72 Volatility6.34% 8.19%
OptionableYes Debt/Eq3.06 EPS Q/Q87.20% Profit Margin- Rel Volume0.44 Prev Close0.20
ShortableYes LT Debt/Eq2.06 EarningsAug 14 BMO Payout- Avg Volume6.61M Price0.19
Recom2.00 SMA20-10.56% SMA50-27.78% SMA200-28.24% Volume2,904,138 Change-6.02%
Jun-26-19Initiated Maxim Group Buy $4
Nov-10-17Downgrade ROTH Capital Buy → Neutral
Sep-18-20 04:45PM  
Titan Pharmaceuticals' Stockholders Approve Proposal To Amend Its Certificate Of Incorporation
PR Newswire
Sep-16-20 01:05PM  
Here's What We Think About Titan Pharmaceuticals' (NASDAQ:TTNP) CEO Pay
Simply Wall St.
Sep-15-20 08:30AM  
Titan's Probuphine® Commercialization Partner, Molteni, Enters Into Exclusive European Distribution Agreement With Accord Healthcare
PR Newswire +16.47%
Sep-14-20 08:30AM  
Titan Pharmaceuticals Provides Update To Stockholders On Proposal To Amend Its Certificate Of Incorporation
PR Newswire -8.43%
Aug-26-20 05:45AM  
TTNP: Indegene to Advance Probuphine Commercialization
Zacks Small Cap Research
Aug-14-20 08:45AM  
Titan Pharmaceuticals Reports Second Quarter 2020 Financial Results
PR Newswire -5.76%
Aug-10-20 04:30PM  
Titan Pharmaceuticals To Report Second Quarter 2020 Financial Results On August 14, 2020
PR Newswire
Jul-08-20 08:00AM  
Titan Pharmaceuticals Urges Stockholders to Vote "FOR" Proposal to Amend Its Certificate of Incorporation
PR Newswire
Jun-24-20 08:00AM  
Titan Pharmaceuticals And Indegene Enter Into Probuphine® Co-Promotion Partnership
PR Newswire +24.03%
Jun-16-20 08:00AM  
Titan Pharmaceuticals Launches Virtual REMS Training For Probuphine Health Care Providers
PR Newswire
Jun-01-20 05:20AM  
TTNP: First Quarter 2020 Financial and Operational Results
Zacks Small Cap Research
May-15-20 08:45AM  
Titan Pharmaceuticals Reports First Quarter 2020 Financial Results
PR Newswire -19.14%
May-11-20 04:03PM  
Titan Pharmaceuticals To Report First Quarter 2020 Financial Results On May 15, 2020
PR Newswire
Apr-09-20 06:15AM  
TTNP: Full Year 2019 Financial and Operational Results
Zacks Small Cap Research
Apr-02-20 09:47PM  
Edited Transcript of TTNP earnings conference call or presentation 30-Mar-20 8:30pm GMT
Thomson Reuters StreetEvents
Mar-31-20 12:43PM  
Penny Stocks to Buy Using Technical Analysis for April 2020
Investopedia -14.65%
Mar-30-20 04:03PM  
Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2019 Financial Results
PR Newswire +9.20%
02:30PM  
Titan Pharmaceuticals, Inc. to Host Earnings Call
ACCESSWIRE
Mar-26-20 08:00AM  
Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2019 Financial Results On March 30, 2020
PR Newswire
Mar-05-20 09:00AM  
Titan Pharmaceuticals Receives $5.9 Million From Exercise Of Warrants
PR Newswire +12.57%
Feb-18-20 08:55AM  
Did Changing Sentiment Drive Titan Pharmaceuticals's (NASDAQ:TTNP) Share Price Down A Disastrous 99%?
Simply Wall St.
Jan-13-20 08:00AM  
Titan Pharmaceuticals Announces Addition Of Probuphine® To Federal Supply Schedule
PR Newswire
Jan-07-20 09:15AM  
Titan Pharmaceuticals Announces Pricing of $2.2 Million Registered Direct Offering
PR Newswire -19.83%
Dec-30-19 08:00AM  
Titan Pharmaceuticals Appoints Dr. Kate DeVarney To Its Board Of Directors
PR Newswire +22.72%
Dec-17-19 10:30AM  
Should You Worry About Titan Pharmaceuticals, Inc.'s (NASDAQ:TTNP) CEO Pay?
Simply Wall St.
Dec-04-19 01:22PM  
Edited Transcript of TTNP earnings conference call or presentation 14-Nov-19 9:30pm GMT
Thomson Reuters StreetEvents
Dec-03-19 09:00AM  
Titan Pharmaceuticals To Present At The First Annual BioTuesdays Pre-JPM Virtual Conference
PR Newswire +20.43%
Nov-25-19 05:15AM  
TTNP: Waiting for Revenue Turn
Zacks Small Cap Research
Nov-14-19 04:03PM  
Titan Pharmaceuticals Reports Third Quarter 2019 Financial Results
PR Newswire +12.04%
Nov-07-19 04:30PM  
Titan Pharmaceuticals To Release Third Quarter 2019 Financial Results On November 14 - Conference Call To Follow
PR Newswire
Oct-22-19 08:00AM  
Titan Pharmaceuticals To Present Two Posters On Probuphine® At The 10th American Conference On Pharmacometrics
PR Newswire
Oct-18-19 10:23AM  
These 24 Bay Area drug and diagnostics companies quietly raised nearly $3B this year
American City Business Journals +5.11%
Oct-16-19 09:20AM  
Titan Pharmaceuticals Announces Pricing Of $9.0 Million Underwritten Public Offering
PR Newswire -51.02%
Oct-01-19 08:00AM  
Titan Pharmaceuticals and Crossroads of Southern Nevada Announce Probuphine® Availability at Crossroads Rehabilitation Facilities
PR Newswire
Sep-18-19 08:00AM  
Titan Receives Approval For Second Year Of NIDA Grant Funding For Development Of A Nalmefene Implant
PR Newswire +20.91%
Aug-30-19 08:01PM  
Edited Transcript of TTNP earnings conference call or presentation 14-Aug-19 8:30pm GMT
Thomson Reuters StreetEvents
Aug-23-19 11:30AM  
TTNP: Long on Opportunity, Short on Capital
Zacks Small Cap Research -6.17%
Aug-17-19 09:59AM  
Some Titan Pharmaceuticals (NASDAQ:TTNP) Shareholders Have Copped A 99% Share Price Wipe Out
Simply Wall St.
Aug-16-19 07:33AM  
The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission
Benzinga +7.51%
Aug-14-19 04:03PM  
Titan Pharmaceuticals Reports Second Quarter 2019 Financial Results
PR Newswire
07:32AM  
Q2 Earnings Preview For Titan Pharmaceuticals
Benzinga
Aug-09-19 05:00PM  
Titan Pharmaceuticals To Release Second Quarter 2019 Financial Results On August 14 - Conference Call To Follow
PR Newswire
Aug-07-19 09:15AM  
Titan Pharmaceuticals Announces Pricing Of $2.1 Million Registered Direct Offering
PR Newswire -27.38%
Jul-09-19 09:00AM  
Titan Pharmaceuticals Expands Patient Access To Probuphine® Via Specialty Product Distribution Agreement With CVS Caremark
PR Newswire
Jul-03-19 10:54AM  
What Does Titan Pharmaceuticals, Inc.'s (NASDAQ:TTNP) Balance Sheet Tell Us About It?
Simply Wall St.
Jun-26-19 09:10AM  
Titan Pharmaceuticals And Molteni Receive European Regulatory Approval For Probuphine
PR Newswire -5.56%
Jun-04-19 07:00AM  
Titan Pharmaceuticals Partners With Southside To Further Expand Specialty Pharmacy Network For Probuphine®
PR Newswire +11.61%
May-29-19 02:15PM  
TTNP: A+ Partnerships: AllianceRx, AppianRx & Accredo
Zacks Small Cap Research
May-23-19 08:10AM  
Edited Transcript of TTNP earnings conference call or presentation 15-May-19 8:30pm GMT
Thomson Reuters StreetEvents
May-15-19 04:08PM  
Titan Pharmaceuticals: 1Q Earnings Snapshot
Associated Press
04:03PM  
Titan Pharmaceuticals Reports First Quarter 2019 Financial Results
PR Newswire
May-13-19 07:00AM  
Titan Pharmaceuticals Further Expands Patient Access To Probuphine® Via Product Purchase And Supply Agreement With Express Scripts' Specialty Pharmacy, Accredo®
PR Newswire
May-08-19 08:00PM  
Titan Pharmaceuticals To Release First Quarter 2019 Financial Results On May 15 - Conference Call To Follow
PR Newswire
May-06-19 03:12PM  
Edited Transcript of TTNP earnings conference call or presentation 2-Apr-19 12:30pm GMT
Thomson Reuters StreetEvents
Apr-29-19 07:00AM  
Titan Pharmaceuticals And Molteni Announce Positive EU CHMP Opinion For Probuphine®
PR Newswire
Apr-12-19 05:00PM  
Knight Therapeutics: Use of PROBUPHINE for Opioid Disorder Gains Momentum Across Canada; Subdermal Implant Now in Use from Coast to Coast
GlobeNewswire
Apr-11-19 09:45AM  
TTNP: EMA Approval of Probuphine Expected 2Q:19
Zacks Small Cap Research
Apr-02-19 01:06AM  
/C O R R E C T I O N -- Titan Pharmaceuticals, Inc./
PR Newswire
Apr-01-19 05:07PM  
Titan Pharmaceuticals: 4Q Earnings Snapshot
Associated Press
04:30PM  
Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results
PR Newswire
Mar-28-19 07:00AM  
Titan Pharmaceuticals Partners With AppianRx To Provide Comprehensive Probuphine® Patient Support Services
PR Newswire
Mar-26-19 07:00AM  
Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2018 Financial Results On April 1, 2019
PR Newswire
Feb-25-19 02:20PM  
4 Healthcare Stocks Looking To Kick Off A Strong Week
ACCESSWIRE +27.78%
07:00AM  
Titan Pharmaceuticals Partners With AllianceRx Walgreens Prime Specialty Pharmacy To Expand Patient Access To Probuphine®
PR Newswire
Feb-08-19 09:30AM  
TTNP: Shipments Spike in 2H:18
Zacks Small Cap Research
Feb-01-19 02:31PM  
4 Healthcare Stocks Looking To Start February Off Strong
ACCESSWIRE +34.15%
12:01PM  
How Many Insiders Bought Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Shares?
Simply Wall St.
11:46AM  
Why Titan Pharmaceuticals Stock Is Skyrocketing Today
InvestorPlace
11:10AM  
Pipeline Update, Review and Progress Titan Pharmaceuticals, Inc.
ACCESSWIRE
Jan-31-19 06:36PM  
Titan Pharmaceuticals Reports Positive Initial Results Of Probuphine® Relaunch
PR Newswire
Jan-24-19 07:00AM  
Titan Pharmaceuticals Announces Reverse Stock Split
PR Newswire
Dec-21-18 12:54PM  
Edited Transcript of TTNP earnings conference call or presentation 14-Nov-18 9:15pm GMT
Thomson Reuters StreetEvents -8.56%
Dec-10-18 10:35AM  
Alternatives to Watch
ACCESSWIRE
Nov-21-18 07:25AM  
Factors of Influence in 2018, Key Indicators and Opportunity within Atlantic American, Titan Medical, Adial Pharmaceuticals, Aptinyx, Sotherly Hotels, and Titan Pharmaceuticals New Research Emphasizes Economic Growth
GlobeNewswire
Nov-20-18 11:15AM  
TTNP: New CCO Implementing Targeted Strategy
Zacks Small Cap Research
Nov-14-18 04:38PM  
Titan Pharmaceuticals: 3Q Earnings Snapshot
Associated Press +10.23%
04:01PM  
Titan Pharmaceuticals Reports Third Quarter 2018 Financial Results
PR Newswire
Nov-08-18 07:00AM  
Titan Pharmaceuticals Schedules Conference Call To Review Third Quarter 2018 Financial Results
PR Newswire
Nov-07-18 09:30AM  
Biotech Stocks and the Midterm Elections
ACCESSWIRE
Nov-05-18 08:55AM  
3 Stocks To Watch As Healthcare Market Evolves
ACCESSWIRE +18.74%
07:00AM  
Todays Research Reports on Stocks to Watch: Conatus Pharmaceuticals and Titan Pharmaceuticals
ACCESSWIRE
Nov-02-18 10:30AM  
Surge In Healthcare Growth Sees Rally In These 3 Stocks On Friday
ACCESSWIRE +22.62%
Oct-30-18 09:45AM  
3 Healthcare Stocks that Could Move on Industry Growth
ACCESSWIRE -5.92%
Oct-29-18 08:00AM  
Knight Therapeutics Announces the Canadian launch of PROBUPHINE for Opioid Use Disorder
GlobeNewswire
Oct-23-18 02:40PM  
These 3 Stocks Are Moving Higher This Month
ACCESSWIRE +36.36%
Oct-22-18 08:00AM  
Today's Research Reports on Trending Tickers: Titan Pharmaceuticals and Amarin Corporation
ACCESSWIRE -6.98%
Oct-15-18 08:15AM  
Titan Pharmaceuticals Moving Forward with its ProNeura Technology, Analysts Review
ACCESSWIRE +11.88%
Oct-02-18 07:00AM  
Titan Strengthens Executive Leadership Team With Appointment Of Chief Commercial Officer
PR Newswire -5.62%
Sep-20-18 08:30PM  
Titan Pharmaceuticals Prices $9,500,000 Public Offering
PR Newswire -10.71%
09:32AM  
Who Owns Titan Pharmaceuticals Inc (NASDAQ:TTNP)?
Simply Wall St.
Sep-10-18 07:00AM  
Titan Awarded NIDA Grant For The Development Of A Nalmefene Implant For The Prevention Of Opioid Addiction Relapse
PR Newswire
Aug-20-18 05:55PM  
Why this Peninsula company needs a cash fix 2 years after opioid addiction treatment approved
American City Business Journals +9.70%
Aug-14-18 04:55PM  
Titan Pharmaceuticals: 2Q Earnings Snapshot
Associated Press
04:35PM  
Titan Pharmaceuticals Reports Second Quarter 2018 Financial Results
PR Newswire
Aug-03-18 07:00AM  
Titan Announces Amendment To Agreement With Molteni
PR Newswire
Jul-02-18 04:30PM  
Titan Pharmaceuticals Provides Update On Parkinson's Disease Clinical Development Program
PR Newswire
May-30-18 07:00AM  
Titan Pharmaceuticals And Braeburn Announce Mutual Termination Of License Agreement For Probuphine® For Opioid Dependence
PR Newswire +13.62%
May-24-18 02:03PM  
Edited Transcript of TTNP earnings conference call or presentation 16-May-18 8:15pm GMT
Thomson Reuters StreetEvents
May-16-18 08:10AM  
Benzinga's Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings
Benzinga
May-15-18 04:40PM  
Titan Pharmaceuticals: 1Q Earnings Snapshot
Associated Press
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company offers Probuphine, a six-month buprenorphine implant for the maintenance treatment of opioid addiction in patients. It also develops ProNeura-Ropinirole, an implant to provide delivery of ropinirole, a dopamine agonist for the treatment of Parkinson's disease; and triiodothyronine, an implant for the treatment of hypothyroidism. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California.
open in yahoo | open in reuters | open in google